Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
220.6 CHF | +0.20% | -2.61% | -9.94% |
Apr. 17 | Roche’s Multiple Sclerosis Injection Controls Relapses, Brain Lesions in Late-stage Trial | MT |
Apr. 17 | Roche: positive phase III results in MS | CF |
Filters
- Stock Market
- Equities
- ROG Stock
- News Roche Holding AG